Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Iovance Biotherapeutics (IOVA) over the last 6 years, with Sep 2025 value amounting to -0.53%.

  • Iovance Biotherapeutics' Return on Capital Employed was N/A to -0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.53%, marking a year-over-year change of. This contributed to the annual value of -0.55% for FY2024, which is N/A change from last year.
  • Per Iovance Biotherapeutics' latest filing, its Return on Capital Employed stood at -0.53% for Q3 2025, which was down 5.00% from -0.51% recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Return on Capital Employed ranged from a high of -0.42% in Q2 2023 and a low of -0.65% during Q4 2023.
  • In the last 3 years, Iovance Biotherapeutics' Return on Capital Employed had a median value of -0.52% in 2025 and averaged -0.52%.
  • Per our database at Business Quant, Iovance Biotherapeutics' Return on Capital Employed dropped by 21bps in 2024 and then rose by 14bps in 2025.
  • Iovance Biotherapeutics' Return on Capital Employed (Quarterly) stood at -0.65% in 2023, then declined by 21bps to -0.63% in 2024, then climbed by 14bps to -0.53% in 2025.
  • Its Return on Capital Employed stands at -0.53% for Q3 2025, versus -0.51% for Q2 2025 and -0.49% for Q1 2025.